Author

Chiara Lonigro

Ghent UniversityORCID 0000-0002-9523-7929Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:database / resource· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1 Organism:rat· 1 Organism:yeast· 1

Frequent Co-Authors

Daria FijałkowskaiD· 2 shared Dries Van HerpeiD· 2 shared Gitte MichielseniD· 2 shared Hannah EeckhautiD· 2 shared Loes van SchieiD· 2 shared Nico CallewaertiD· 2 shared Sandrine VanmarckeiD· 2 shared Alison V. TurneriD· 1 shared

Activity by Year

2021-2022 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersMolecular Biology

Daria FijałkowskaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

OPENPichia: building a free-to-operate Komagataella phaffii protein expression toolkit

Dries Van Herpe, Robin Vanluchene, Kristof Vandewalle, Sandrine Vanmarcke, Elise Wyseure, Berre Van Moer, Hannah Eeckhaut, Daria Fijałkowska, Hendrik Grootaert, Chiara Lonigro, Leander Meuris, Gitte Michielsen, Justine Naessens, Charlotte Roels, Loes van Schie, , Nico Callewaert

The paper develops an open-source yeast chassis, OPENPichia, for synthetic biology by reverse engineering and characterizing industrial Pichia strains.

bioRxiv · Dec 13, 2022 · PreprintMolecular Biology

Drug development of an affinity enhanced, broadly neutralizing heavy chain-only antibody that restricts SARS-CoV-2 in rodents

Bert Schepens, Loes van Schie, Wim Nerinckx, Kenny Roose, Wander Van Breedam, Daria Fijałkowska, Simon Devos, Wannes Weyts, Sieglinde De Cae, Sandrine Vanmarcke, Chiara Lonigro, Hannah Eeckhaut, Dries Van Herpe, Jimmy Borloo, ANDREZA ESTEFANY DA SILVA OLIVEIRA, , Xavier Saelens

The paper describes the development of a broadly neutralizing antibody, XVR011, effective against SARS-CoV-2 and its variants in animal models.

bioRxiv · Mar 8, 2021 · PreprintMolecular Biology